Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zimlab.in | |
Market Cap | 378.79 Cr. | |
Enterprise Value(EV) | 434.35 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 4.97 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 15.63 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.70 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 46.26 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.68 | Calculated using Price: 77.74 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.87 Cr. | 48,725,814 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India. |
1 Day |
|
-0.19% |
1 Week |
|
+0.13% |
1 Month |
|
+6.78% |
3 Month |
|
-32.79% |
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
8 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -22.94 | 5.29 | 17.21 | 15.07 | 10.73 | 2.17 | 4.66 | 8.65 | |
Return on Capital Employed (%) | -8.70 | 9.95 | 14.20 | 16.46 | 14.64 | 5.39 | 8.70 | 12.52 | |
Return on Assets (%) | -8.12 | 1.95 | 7.33 | 7.02 | 4.93 | 1.02 | 2.28 | 4.37 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 94 | 99 | 118 | 137 | 151 | 154 | 161 | 176 | 187 | |
Non Curr. Liab. | 38 | 35 | 18 | 17 | 20 | 23 | 19 | 20 | 24 | |
Curr. Liab. | 134 | 124 | 113 | 141 | 156 | 143 | 142 | 147 | 132 | |
Minority Int. | ||||||||||
Equity & Liab. | 266 | 257 | 250 | 295 | 328 | 320 | 322 | 343 | 344 | |
Non Curr. Assets | 97 | 102 | 96 | 122 | 132 | 138 | 130 | 129 | 134 | |
Curr. Assets | 169 | 155 | 154 | 173 | 195 | 182 | 192 | 214 | 210 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 266 | 257 | 250 | 295 | 328 | 320 | 322 | 343 | 344 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 266 | 269 | 235 | 273 | 335 | 278 | 307 | 333 | 398 | |
Other Income | 2 | 4 | 6 | 3 | 2 | 5 | 2 | 4 | 7 | |
Total Income | 269 | 272 | 241 | 276 | 337 | 282 | 310 | 338 | 406 | |
Total Expenditure | -245 | -239 | -204 | -238 | -293 | -255 | -268 | -292 | -347 | |
PBIDT | 24 | 33 | 37 | 38 | 44 | 27 | 42 | 45 | 59 | |
Interest | -10 | -14 | -10 | -9 | -11 | -13 | -11 | -8 | -6 | |
Depreciation | -7 | -9 | -9 | -10 | -11 | -14 | -16 | -16 | -17 | |
Taxation | 5 | 0 | 1 | -6 | -7 | 3 | -3 | -6 | -12 | |
Exceptional Items | -33 | -5 | 6 | -5 | ||||||
PAT | -22 | 5 | 19 | 19 | 15 | 3 | 7 | 15 | 24 | |
Minority Interest | ||||||||||
Share Associate | ||||||||||
Other Related Items | ||||||||||
Consolidated Net Profit | -22 | 5 | 19 | 19 | 15 | 3 | 7 | 15 | 24 | |
Adjusted EPS | -5 | 1 | 4 | 4 | 3 | 1 | 2 | 3 | 5 |
Particulars | 8 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 6 | 22 | 32 | 37 | 35 | 22 | 32 | 49 | |
Cash Fr. Inv. | -9 | -12 | -7 | -26 | -21 | -19 | -6 | -15 | |
Cash Fr. Finan. | -3 | -10 | -25 | -10 | -15 | -2 | -26 | -33 | |
Net Change | -7 | 0 | 0 | 1 | -1 | 0 | 2 | ||
Cash & Cash Eqvt | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 3 |
Tue, 21 Mar 2023
Loss of Share Certificates
|
|
Fri, 17 Mar 2023
Loss of Share Certificates
|
|
Thu, 16 Mar 2023
Loss of Share Certificates
|
Tue, 21 Mar 2023 |
|
|
|
|
|